课题基金 / 基金详情

Cochlear gene therapy targeting the protection against aging related hearing loss and neuronal degeneration

Cochlear gene therapy targeting the protection against aging related hearing loss and neuronal degeneration
耳蜗基因疗法旨在预防与衰老相关的听力损失和神经元变性
批准号:
304476
负责人:
Wang Jian
金额:
$18.25万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2014
资助国家:
加拿大
项目状态:
已结题
起止时间:
2014-03-01 至 2016-03-01

项目摘要

项目成果

Wang Jian的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Age-related hearing loss (AHL), or presbycusis, impacts more than 40% of people over 65 by decreasing their communication ability as well as increasing the risk of dementia. AHL is accelerated by noise exposure. There is no medical treatment right now or
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Canada Research Chair Tier 1
Factuality and Mechanisms of Promoting Effect of Hearing Loss on Age-related Cognitive Impairment
  • 批准号:
    366619
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2016
  • 负责人:
    Wang Jian
  • 依托单位:
Protection against apoptosis in presbycusis and noise/drug induced hearing loss by cochlear transfection of xiap gene in experimental animals
  • 批准号:
    171095
  • 项目类别:
    Operating Grants
  • 资助金额:
    $37.51万
  • 财政年份:
    2008
  • 负责人:
    Wang Jian
  • 依托单位: